L26/P-566 Avoidable lifestyle exposure to endocrine disruptors with potential impact on fertility: a pilot study
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Ballester und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Do current lifestyle habits promote avoidable exposure to endocrine disruptors with potential implications for female fertility? Summary answer All urine (20/20) and follicular-fluid samples collected (19/19) contained ≥1 EDC biomarker; DEHP were detected in 100% of both matrices; survey data identified modifiable sources. What is known already Endocrine-disrupting chemicals (EDCs) can interfere with endocrine function and reproductive health. Biomonitoring studies frequently detect phthalate metabolites, bisphenols and parabens in urine. Follicular fluid reflects the peri-ovulatory microenvironment surrounding the oocyte, yet prevention remains limited by insufficient identification of individual exposure sources, especially daily-use and intimate-hygiene products where mucosal absorption may be relevant. Study design, size, duration Pilot cross-sectional observational study. Twenty women of reproductive age undergoing oocyte retrieval were enrolled. Urine and follicular fluid were collected on the day of follicular aspiration; follicular fluid was available for 19/20 participants. Participants/materials, setting, methods A nursing-led structured questionnaire captured potential EDC exposure sources (personal care and intimate-hygiene products with brand/product identification, menstrual hygiene, cleaning products and dietary habits) to support individualized counselling. Urine and follicular fluid were analysed by chromatographic methods coupled to mass spectrometry (depending on analyte) for presence/absence of BPA, DEHP biomarkers, PFAS, dioxins, parabens, phthalates and benzophenones. Outcomes were detection frequencies and descriptive exposure patterns. Main results and the role of chance At least one EDC was detected in urine in 20/20 participants (100%) and in follicular fluid in 19/19 samples (100%). In urine, DEHP biomarkers were detected in 20/20 (100%), while BPA, PFAS, dioxins, parabens, phthalates and benzophenones were each detected in 18/20 (90%). In follicular fluid, DEHP biomarkers were detected in all samples BPA was detected in 15/19 (78.9%); and PFAS, dioxins, parabens, phthalates and benzophenones were each detected in 17/19 (89.5%). One participant showed a restricted follicular-fluid profile with DEHP detected but other assessed families not detected. INCI-labelled ingredient list review showed that 84.7% of the daily-use products reported contained at least one endocrine-disrupting ingredient. The questionnaire enabled systematic documentation of daily product use, supporting identification of potentially modifiable exposure sources and providing a practical framework for individualized nursing counselling. Given the pilot design, findings are interpreted as descriptive and hypothesis-generating. Limitations, reasons for caution Small sample size and cross-sectional design limit causal inference and generalizability. The panel reflects selected families and presence/absence rather than full exposure characterization. Self-reported product use may introduce recall bias. Broader laboratory panels and larger cohorts are needed to assess clinical relevance. Wider implications of the findings High detection of multiple EDC families in urine and follicular fluid supports integrating exposure assessment into reproductive health care pathways. Nurse-led, source-focused counselling, particularly regarding intimate-hygiene and daily-use products, may be a feasible prevention strategy to promote reproductive health and inform larger IVF studies evaluating oocyte and embryo outcomes. Trial registration number No
Zitieren
APA
Ballester, A., Sánchez, M., Hernandez, A., Ruano, M., Poeiras, S., Escudero, M., Ortega, L., Romero, C., Horcajadas, J., & Zavala, A. (2026). L26/P-566 Avoidable lifestyle exposure to endocrine disruptors with potential impact on fertility: a pilot study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.899
Vancouver
Ballester A, Sánchez M, Hernandez A, Ruano M, Poeiras S, Escudero M, et al. L26/P-566 Avoidable lifestyle exposure to endocrine disruptors with potential impact on fertility: a pilot study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.899
BibTeX
@article{Ballester2026,
author = {Ballester, A. and Sánchez, M. and Hernandez, A. and Ruano, M. and Poeiras, S. and Escudero, M.D. and Ortega, L. and Romero, C. and Horcajadas, J. and Zavala, A.},
title = {L26/P-566 Avoidable lifestyle exposure to endocrine disruptors with potential impact on fertility: a pilot study},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.899}
}
EUVIMED